Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment

Journal of Proteome Research

Volumn 9, Issue 2, 2010, Pages 1129-1137

  Lei, Xiong ^a   Yinsheng, Wang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute promyelocytic leukemia; Arsenite; Fatty acid synthase; Mass spectrometry; Protein quantification; SILAC

Indexed keywords

ALPHA ENOLASE; ALPHA MANNOSIDASE; AMINO ACID; ARSENIC TRIOXIDE; CATHEPSIN D; DEAD BOX PROTEIN; ELONGATION FACTOR 2; FATTY ACID; FATTY ACID SYNTHASE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; HISTONE; HISTONE H1B; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HLA ANTIGEN CLASS 1; LEUKOCYTE ELASTASE; PALMITIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN; PROTEIN PHOSPHATASE 1 ALPHA; RIBOSOMAL PROTEIN S25; SPERMIDINE SYNTHASE; STABLE ISOTOPE; THREONINE TRANSFER RNA LIGASE; TXNDC5 PROTEIN; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL STRAIN HL 60; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UPREGULATION;

ARSENITES; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACID SYNTHETASE COMPLEX; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HL-60 CELLS; HUMANS; ISOTOPE LABELING; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 76149138039     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9011359     Document Type: Article

References (55)

1. National Research Council, Arsenic in Drinking Water; National Academy Press: Washington DC, 1999; and 2001 update.
2. Abernathy, C. O.; Liu, Y. P.; Longfellow, D.; Aposhian, H. V.; Beck, B.; Fowler, B.; Goyer, R.; Menzer, R.; Rossman, T.; Thompson, C.; Waalkes, M. Arsenic: Health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 1999, 107, 593-597.
3. Morales, K. H.; Ryan, L.; Kuo, T. L.; Wu, M. M.; Chen, C. J. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 2000, 108, 655-661.
4. Cantor, K. P.; Lubin, J. H. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol. Appl. Pharmacol. 2007, 222, 252-7.
5. 3 exerts dose-dependent dual effects on APL cells. Blood 1997, 89, 3345-3353.
6. 3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996, 88, 1052-1061.
7. Zhu, J.; Chen, Z.; Lallemand-Breitenbach, V.; de The, H. How acute promyelocytic leukaemia revived arsenic. Nat. Rev. Cancer 2002, 2, 705-713.
8. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997, 89, 3354-3360.
9. Lerda, D. Sister-chromatid exchange (Sce) among individuals chronically exposed to arsenic in drinking-water. Mutat. Res. 1994, 312, 111-120.
10. Gonsebatt, M. E.; Vega, L.; Salazar, A. M.; Montero, R.; Guzman, P.; Blas, J.; DelRazo, L. M.; GarciaVargas, G.; Albores, A.; Cebrian, M. E.; Kelsh, M.; OstroskyWegman, P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 1997, 386, 219-228.
11. Yan, H.; Wang, N.; Weinfeld, M.; Cullen, W. R.; Le, X. C. Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry. Anal. Chem. 2009, 81, 4144-4152.
12. Liu, S. X.; Athar, M.; Lippai, I.; Waldren, C.; Hei, T. K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1643-1648.
13. Kitchin, K. T. Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 2001, 172, 249-261.
14. Yih, L. H.; Peck, K.; Lee, T. C. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 2002, 23, 867-876.
15. Wilkins, M. R.; Sanchez, J. C.; Williams, K. L.; Hochstrasser, D. F. Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 1996, 17, 830-838.
16. Klose, J.; Kobalz, U. 2-Dimensional electrophoresis of proteinssan updated protocol and implications for a functional-analysis of the genome. Electrophoresis 1995, 16, 1034-1059.
17. Castagna, A.; Antonioli, P.; Astner, H.; Hamdan, M.; Righetti, S. C.; Perego, P.; Zunino, F.; Righetti, P. G. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 2004, 4, 3246-3267.
18. Sinha, P.; Poland, J.; Kohl, S.; Schnolzer, M.; Helmbach, H.; Hutter, G.; Lage, H.; Schadendorf, D. Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 2003, 24, 2386-2404.
19. Urbani, A.; Poland, J.; Bernardini, S.; Bellincampi, L.; Biroccio, A.; Schnolzer, M.; Sinha, P.; Federici, G. A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines. Proteomics 2005, 5, 796-804.
20. Bertagnolo, V.; Grassilli, S.; Bavelloni, A.; Brugnoli, F.; Piazzi, M.; Candiano, G.; Petretto, A.; Benedusi, M.; Capitani, S. Vav1 modulates protein expression during ATRA-induced maturation of APLderived promyelocytes: A proteomic-based analysis. J. Proteome Res. 2008, 7, 3729-3736.
21. Lau, A. T.; He, Q. Y.; Chiu, J. F. A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem. J. 2004, 382, 641-650.
22. Tapio, S.; Danescu-Mayer, J.; Asmuss, M.; Posch, A.; Gomolka, M.; Hornhardt, S. Combined effects of gamma radiation and arsenite on the proteome of human TK6 lymphoblastoid cells. Mutat. Res. 2005, 581, 141-152.
23. Berglund, S. R.; Santana, A. R.; Li, D.; Rice, R. H.; Rocke, D. M.; Goldberg, Z. Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes. Proteomics 2009, 9, 1925-1938.
24. Zheng, P. Z.; Wang, K. K.; Zhang, Q. Y.; Huang, Q. H.; Du, Y. Z.; Zhang, Q. H.; Xiao, D. K.; Shen, S. H.; Imbeaud, S.; Eveno, E.; Zhao, C. J.; Chen, Y. L.; Fan, H. Y.; Waxman, S.; Auffray, C.; Jin, G.; Chen, S. J.; Chen, Z.; Zhang, J. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 7653-7658.
25. Ge, F.; Lu, X. P.; Zeng, H. L.; He, Q. Y.; Xiong, S.; Jin, L. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J. Proteome Res. 2009, 8, 3006-3019.
26. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
27. Ross, P. L.; Huang, Y. L. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
28. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture SILAC as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
29. Wiseman, R. L.; Chin, K. T.; Haynes, C. M.; Stanhill, A.; Xu, C. F.; Roguev, A.; Krogan, N. J.; Neubert, T. A.; Ron, D. Thioredoxinrelated Protein 32 is an arsenite-regulated thiol reductase of the proteasome 19 S particle. J. Biol. Chem. 2009, 284, 15233-15245.
30. Van Harken, D. R.; Dixon, C. W.; Heimberg, M. Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J. Biol. Chem. 1969, 244, 2278-2285.
31. Romijn, E. P.; Christis, C.; Wieffer, M.; Gouw, J. W.; Fullaondo, A.; van der Sluijs, P.; Braakman, I.; Heck, A. J. R. Expression clustering reveals detailed coexpression patterns of functionally related proteins during B cell differentiationsA proteomic study using a combination of one-dimensional gel electrophoresis, LC-MS/MS, and stable isotope labeling by amino acids in cell culture (SILAC). Mol. Cell. Proteomics 2005, 4, 1297-1310.
32. Uitto, P. M.; Lance, B. K.; Wood, G. R.; Sherman, J.; Baker, M. S.; Molloy, M. P. Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells. J. Proteome Res. 2007, 6, 2105-2112.
33. Zhang, T. D.; Chen, G. Q.; Wang, Z. G.; Wang, Z. Y.; Chen, S. J.; Chen, Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene 2001, 20, 7146-7153.
34. Douer, D.; Tallman, M. S. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J. Clin. Oncol. 2005, 23, 2396-2410.
35. Lennartsson, A.; Ekwall, K. Histone modification patterns and epigenetic codes. Biochim. Biophys. Acta 2009, 1790, 863-868.
36. Zhou, X.; Sun, H.; Ellen, T. P.; Chen, H. B.; Costa, M. Arsenite alters global histone H3 methylation. Carcinogenesis 2008, 29, 1831-1836.
37. Othumpangat, S.; Kashon, M.; Joseph, P. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death. Mol. Cell. Biochem. 2005, 279, 123-131.
38. Wakil, S. J. Fatty-acid synthase, a proficient multifunctional enzyme. Biochemistry 1989, 28, 4523-4530.
39. Kuhajda, F. P. Fatty acid synthase and cancer: New application of an old pathway. Cancer Res. 2006, 66, 5977-5980.
40. Funabashi, H.; Kawaguchi, A.; Tomoda, H.; Omura, S.; Okuda, S.; Iwasaki, S. Binding site of cerulenin in fatty acid synthetase. J. Biochem. 1989, 105, 751-755.
41. Omura, S. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol. Rev. 1976, 40, 681-697.
42. Pizer, E. S.; Wood, F. D.; Pasternack, G. R.; Kuhajda, F. P. Fatty acid synthase (FAS): A target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res. 1996, 56, 745-751.
43. Furuta, E.; Pai, S. K.; Zhan, R.; Bandyopadhyay, S.; Watabe, M.; Mo, Y. Y.; Hirota, S.; Hosobe, S.; Tsukada, T.; Miura, K.; Kamada, S.; Saito, K.; Iiizumi, M.; Liu, W.; Ericsson, J.; Watabe, K. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008, 68, 1003-1011.
44. Yang, Y. A.; Han, W. F.; Morin, P. J.; Chrest, F. J.; Pizer, E. S. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res. 2002, 279, 80-90.
45. D'Erchia, A. M.; Tullo, A.; Lefkimmiatis, K.; Saccone, C.; Sbisa, E. The fatty acid synthase gene is a conserved p53 family target from worm to human. Cell Cycle 2006, 5, 750-758.
46. Lane, A. A.; Ley, T. J. Neutrophil elastase cleaves PML-RAR alpha and is important for the development of acute promyelocytic leukemia in mice. Cell 2003, 115, 305-318.
47. Kitareewan, S.; Roebuck, B. D.; Demidenko, E.; Sloboda, R. D.; Dmitrovsky, E. Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J. Natl. Cancer Inst. 2007, 99, 41-52.
48. Benes, P.; Vetvicka, V.; Fusek, M. Cathepsin D - many functions of one aspartic protease. Crit. Rev. Oncol. Hematol. 2008, 68, 12-28.
49. Jaattela, M.; Cande, C.; Kroemer, G. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ. 2004, 11, 135-136.
50. Wu, G. S.; Saftig, P.; Peters, C.; El-Deiry, W. S. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998, 16, 2177-2183.
51. Karapetian, R. N.; Evstafieva, A. G.; Abaeva, I. S.; Chichkova, N. V.; Filonov, G. S.; Rubtsov, Y. P.; Sukhacheva, E. A.; Melnikov, S. V.; Schneider, U.; Wanker, E. E.; Vartapetian, A. B. Nuclear oncoprotein prothymosin α is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell. Biol. 2005, 25, 1089-1099.
52. Hayes, J. D.; McMahon, M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 2001, 174, 103-113.
53. Ishii, T.; Itoh, K.; Takahashi, S.; Sato, H.; Yanagawa, T.; Katoh, Y.; Bannai, S.; Yamamoto, M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275, 16023-16029.
54. Snow, E. T.; Sykora, P.; Durham, T. R.; Klein, C. B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk. Toxicol. Appl. Pharmacol. 2005, 207, 557-564.
55. Sul, H. S.; Wang, D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu. Rev. Nutr. 1998, 18, 331-351.